Almubayyidh Mohammed, Jenkins David A, Gaude Edoardo, Parry-Jones Adrian R
Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Department of Aviation and Marine, Prince Sultan Bin Abdulaziz College for Emergency Medical Services, King Saud University, Riyadh, Saudi Arabia.
BMJ Neurol Open. 2025 Jun 19;7(1):e001160. doi: 10.1136/bmjno-2025-001160. eCollection 2025.
Accurate and timely differentiation of intracerebral haemorrhage (ICH) from other suspected stroke cases is crucial in prehospital settings, where early blood pressure reduction in the ambulance can improve outcomes. This study aims to assess whether combining clinical predictors and glial fibrillary acidic protein (GFAP) in prediction models can effectively distinguish ICH from other suspected stroke cases.
Data were derived from the Testing for Identification Markers of Stroke trial, a prospective diagnostic accuracy study. Suspected stroke patients within 6 hours of symptom onset were included. Clinical predictors were selected based on known associations with ICH, and a predefined GFAP cut-off of 290 pg/mL was applied. Logistic regression was used to assess the performance of clinical predictors and GFAP, individually and in combination. Internal validation and optimism correction were performed via bootstrapping, and comparisons of the area under the curve (AUC) were conducted using DeLong's test.
We included 209 suspected stroke cases, of which 5% were finally diagnosed with ICH. Clinical predictors alone achieved an optimism-corrected AUC of 0.74 (95% CI 0.60 to 0.88), while GFAP alone resulted in an optimism-corrected AUC of 0.83 (95% CI 0.69 to 0.99). Combining clinical predictors with GFAP significantly enhanced the AUC, yielding an optimism-corrected value of 0.90 (95% CI 0.79 to 0.98). This combined model also demonstrated high predictive accuracy, with an optimism-corrected sensitivity of 60% (95% CI 29.0% to 90.0%) and a specificity of 98% (95% CI 96.1% to 100.0%).
Combining clinical predictors with GFAP shows promise for the prehospital identification of ICH to support transport decision-making and potentially initiate treatment while en route for these patients. Prospective validation using portable point-of-care devices is required to confirm the utility of this approach in the prehospital setting.
在院前环境中,准确及时地将脑出血(ICH)与其他疑似中风病例区分开来至关重要,因为在救护车上尽早降低血压可改善预后。本研究旨在评估在预测模型中结合临床预测指标和胶质纤维酸性蛋白(GFAP)是否能有效区分ICH与其他疑似中风病例。
数据来自中风识别标志物检测试验,这是一项前瞻性诊断准确性研究。纳入症状发作6小时内的疑似中风患者。根据与ICH的已知关联选择临床预测指标,并应用预先定义的GFAP临界值290 pg/mL。采用逻辑回归分别评估临床预测指标和GFAP单独及联合使用时的性能。通过自举法进行内部验证和乐观校正,并使用德龙检验对曲线下面积(AUC)进行比较。
我们纳入了209例疑似中风病例,其中5%最终被诊断为ICH。仅临床预测指标的乐观校正AUC为0.74(95%可信区间0.60至0.88),而仅GFAP的乐观校正AUC为0.83(95%可信区间0.69至0.99)。将临床预测指标与GFAP相结合显著提高了AUC,乐观校正值为0.90(95%可信区间0.79至0.98)。该联合模型还显示出高预测准确性,乐观校正敏感性为60%(95%可信区间29.0%至90.0%),特异性为98%(95%可信区间96.1%至100.0%)。
将临床预测指标与GFAP相结合在院前识别ICH方面显示出前景,有助于支持转运决策,并可能在这些患者的转运途中启动治疗。需要使用便携式即时检测设备进行前瞻性验证,以确认该方法在院前环境中的实用性。